Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Amgen
Blokhin's Russian Cancer Research Center
UMC Utrecht
Blokhin's Russian Cancer Research Center
Neonc Technologies, Inc.
Essen Biotech
xCures
Swansea Bay University Health Board
University of Nebraska
Adela, Inc
M.D. Anderson Cancer Center
Var2 Pharmaceuticals
Novartis
Massive Bio, Inc.
Dana-Farber Cancer Institute
Washington University School of Medicine
Jonsson Comprehensive Cancer Center
Telix Pharmaceuticals (Innovations) Pty Limited
Mayo Clinic
Columbia University
Tempus AI
Shandong Cancer Hospital and Institute
Stanford University
Inova Health Care Services
Universidade Federal de Pernambuco
Aminex Therapeutics, Inc.
Taproot Health
NGM Biopharmaceuticals, Inc
Universitaire Ziekenhuizen KU Leuven
University of Florida
Quadriga Biosciences, Inc.
Weill Medical College of Cornell University
Gilead Sciences
Hospices Civils de Lyon
Shenzhen BinDeBio Ltd.
SpeciCare
University Hospital Tuebingen
Shenzhen BinDeBio Ltd.
Swiss Cancer Institute
Maastricht Radiation Oncology
Ohio State University Comprehensive Cancer Center
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
Shenzhen Second People's Hospital
University of Arizona
Stanford University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco